Inhibition of succinic acid production in metabolically engineered Escherichia coli by neutralizing agent, organic acids, and osmolarity.
The economical viability of biochemical succinic acid production is a result of many processing parameters including final succinic acid concentration, recovery of succinate, and the volumetric productivity. Maintaining volumetric productivities >2.5 g L(-1) h(-1) is important if production of succinic acid from renewable resources should be competitive. In this work, the effects of organic acids, osmolarity, and neutralizing agent (NH4OH, KOH, NaOH, K2CO3, and Na2CO3), and Na2CO3) on the fermentative succinic acid production by Escherichia coli AFP184 were investigated. The highest concentration of succinic acid, 77 g L(-1), was obtained with Na2CO3. In general, irrespective of the base used, succinic acid productivity per viable cell was significantly reduced as the concentration of the produced acid increased. Increased osmolarity resulting from base addition during succinate production only marginally affected the productivity per viable cell. Addition of the osmoprotectant glycine betaine to cultures resulted in an increased aerobic growth rate and anaerobic glucose consumption rate, but decreased succinic acid yield. When using NH4OH productivity completely ceased at a succinic acid concentration of approximately 40 g L(-1). Volumetric productivities remained at 2.5 g L(-1) h(-1) for up to 10 h longer when K- or Na-bases where used instead of NH4OH. The decrease in cellular succinic acid productivity observed during the anaerobic phase was found to be due to increased organic acid concentrations rather than medium osmolarity.
Andersson
Christian
C
Div. of Biochemical and Chemical Process Engineering, Luleå University of Technology, SE-97187, Luleå, Sweden.
Helmerius
Jonas
J
Hodge
David
D
Berglund
Kris A
KA
Rova
Ulrika
U
D000143:Acids / Q000494:pharmacology*; D000468:Alkalies / Q000494:pharmacology*; D064753:Ammonium Hydroxide; D002254:Carbonates / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism*; D005285:Fermentation; D015964:Gene Expression Regulation, Bacterial / Q000187:drug effects; D006878:Hydroxides / Q000494:pharmacology; D009994:Osmolar Concentration; D011188:Potassium / Q000494:pharmacology; D017680:Potassium Compounds / Q000494:pharmacology; D012972:Sodium Hydroxide / Q000494:pharmacology; D019802:Succinic Acid / Q000378:metabolism*
D000143:Acids; D000468:Alkalies; D002254:Carbonates; D006878:Hydroxides; D017680:Potassium Compounds; D064753:Ammonium Hydroxide; D012972:Sodium Hydroxide; D019802:Succinic Acid; C037593:potassium carbonate; D011188:Potassium; C029943:potassium hydroxide